This is like saying if there is a successful drug by any other company, that this means every drug company's drugs are going to be successful. No, that's not how it works.
RGBP has nothing to do with Dostarlimab, and because Koos claims to be looking at shit, that doesn't mean he has anything.
Name the current drugs and their status in the RGBP pipeline! And no, patents and papers aren't drugs! lol